The basic science and clinical studies carried out by hematology faculty cover a broad range of hematologic malignancies and blood disorders. Clinical investigators in the Division utilize discoveries from laboratories worldwide to develop and test novel therapeutic approaches to improve patient outcomes.
Overcoming transplant rejection in mice
If the antibody treatment is eventually found to be viable in humans, it could increase the numbers of people who benefit from hematopoietic stem transplants, Stanford researchers said.
Toward radiation-free stem cell transplants
Researchers at Stanford and the University of Tokyo may have cracked the code to doing stem cell transplants and gene therapy without radiation and chemotherapy.
Possible ‘bubble boy’ disease therapy
In preclinical trials, Stanford scientists and their collaborators harnessed the gene-editing system CRISPR-Cas9 to replace the mutated gene underpinning the devastating immune disease.
Gentler pre-transplant treatment with antibody
An antibody to a protein on blood-forming stem cells may allow bone marrow transplants without the need for chemotherapy and radiation, according to a Stanford study.
Transplants without tissue-matching?
Researchers’ experimental approach for preparing mice for blood stem cell transplantation may one day make it possible in humans to safely transplant organs or cells from any donor to any recipient.
Join the Mailing List
New activities are added regularly. Join our mailing list to receive notifications about activities of interest to you.